Novartis announces Q4/Full Year 2011 results

Basel, January 25, 2012 - Novartis delivers strong underlying financial performance in 2011, expects 2012 sales to be in line with 2011

Sandoz initiates two more Phase III biosimilar trials, reinforcing long-term global leadership commitment

Holzkirchen, Germany, January 19, 2012 - Sandoz announced today that it has initiated two milestone Phase III clinical trials - one for biosimilar filgrastim (Amgen's Neupogen®) in the US market, the other for its global pegfilgrastim development program (Amgen's Neulasta®).

Sandoz Head Jeff George Named Top "40 Under 40"

Holzkirchen, Germany - Sandoz is pleased to announce that Jeff George, global Head of Sandoz, has been named part of Fortune Magazine’s 2011 Top “40 Under 40”.

New episode of Sandoz TV now available!

October 27, 2011 - Sandoz is pleased to announce that it has launched a new, seventh episode of Sandoz TV.